Product Information
SYMBRAVO 20-10 MG TABLET is a brand product labeled by Axsome Therapeutics, Inc., priced at $122.6769 per EA under NDC 81968002009. Its NADAC has been published 36 times since Oct 22, 2025.
Strength
20; 10 mg/1; mg/1
Manufacturer
Axsome Therapeutics, Inc.NDC
81968002009
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MELOXICAM; RIZATRIPTAN BENZOATEApproval Type
New Drug (NDA)
FDA Application
NDA215431On Market Since
5/19/2025
Pharmacological Classes
Price Statistics
The NADAC for SYMBRAVO 20-10 MG TABLET has been published 36 times since Oct 22, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $122.6769 per EA |
|---|---|
| All-time high | $122.8814 (Dec 10, 2025) |
| All-time low | $122.6760 (Dec 17, 2025) |
| 52-week high | $122.8814 |
| 52-week low | $122.6760 |
| Median price | $122.7149 |
| Average price | $122.7360 |
| Largest weekly change | -0.2% (Dec 17, 2025) |
| Weeks tracked | 36 |
| Tracking since | Oct 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the meloxicam, rizatriptan market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of SYMBRAVO 20-10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SYMBRAVO 20-10 MG TABLET, manufactured by Axsome Therapeutics, Inc., is $122.6769 per EA (NDC 81968002009), effective Jun 24, 2026.
How has the price of SYMBRAVO 20-10 MG TABLET changed over time?
Over the history we have for it, the NADAC for SYMBRAVO 20-10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 36 weekly CMS publications since Oct 22, 2025.
What are the highest and lowest recorded NADAC prices for SYMBRAVO 20-10 MG TABLET?
Since Oct 22, 2025, the NADAC for SYMBRAVO 20-10 MG TABLET has ranged from a low of $122.6760 (Dec 17, 2025) to a high of $122.8814 (Dec 10, 2025), with a median of $122.7149 per EA.
Are there cheaper alternatives to SYMBRAVO 20-10 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of SYMBRAVO 20-10 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures SYMBRAVO 20-10 MG TABLET?
SYMBRAVO 20-10 MG TABLET (NDC 81968002009) is labeled by Axsome Therapeutics, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification